FDA now providing validation, letter of support for @SOSVvc @indbio backed @sRNAlytics - which identifies biomarkers for key neurocognitive disorders
#GoodDiagnostics -> #GoodTherapeutics
Help is on the way...
Proud to support @sRNAlytics on their journey for developing biomarkers/predictors for key neurocognitive disorders... 20 years in advance
#Backed by @SOSVvc @indbio#NowFDAsupported
We are excited to share this great news: we received a Letter of Support from the FDA promoting the use of our sRNA-FIND platform in the discovery of Huntington's Disease biomarkers 20 years prior to symptom onset! #AI#FDA https://t.co/bEeuGwyoD8
We are excited to share this great news: we received a Letter of Support from the FDA promoting the use of our sRNA-FIND platform in the discovery of Huntington's Disease biomarkers 20 years prior to symptom onset! #AI#FDA https://t.co/bEeuGwyoD8
sRNAlytics identifies patterns of small RNA changes and uses artificial intelligence algorithms to identify what part of the body they come from, and how they change in different diseases #HDTC
@sRNAlytics classifies disease, facilitating the development of new drugs & enabling their effective use to improve patient outcomes. #IndieBio Class 6
https://t.co/uTwrwOTw7Z
@sRNAlytics - so much potential to use their set of inventions to create a non-coding diagnostics platform first in the brain then beyond; need to see their product on the market
Hello IndieBio Class Six! They are covering therapeutics, cell therapies, food & agriculture and diagnostics for cancer and neurological disease hailing from all over the world. @Beeflow@nuro_corp@Neurocarrus@nbhorwitz
https://t.co/3nCIBQHoDC